We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.8B
AUM Growth
+$3.07B
(+6.9%)
Cap. Flow
-$507M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
1,131
New
130
Increased
292
Reduced
306
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$526M |
| 2 |
Ally Financial
ALLY
|
+$198M |
| 3 |
CSX Corp
CSX
|
+$191M |
| 4 |
NetEase
NTES
|
+$173M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$262M |
| 2 |
CVS Health
CVS
|
+$240M |
| 3 |
Mastercard
MA
|
+$204M |
| 4 |
McKesson
MCK
|
+$201M |
| 5 |
Molson Coors Class B
TAP
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Communication Services | 13.94% |
| 3 | Technology | 12.15% |
| 4 | Financials | 10.5% |
| 5 | Energy | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZIV
426
DELISTED
VelocityShares Daily Inverse VIX Medium Term ETN
ZIV
| $5.64M | 0.01% |
+121,325
| New | +$5.1M |
|
|
VRE
427
DELISTED
Veris Residential
VRE
| $5.55M | 0.01% |
258,400
-53,362
| -17% | -$1.13M |
|
|
PPO
428
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $5.54M | 0.01% |
+116,026
| New | +$4.75M |
|
429
Cohen & Steers
CNS
$4.23B
| $5.5M | 0.01% |
+126,747
| New | +$5.18M |
|
430
LXP Industrial Trust
LXP
$3.53B
| $5.49M | 0.01% |
99,714
-1,330,100
| -93% | -$73.7M |
|
|
EEA
431
European Equity Fund
EEA
$74.2M
| $5.46M | 0.01% |
606,553
-185,131
| -23% | -$1.67M |
|
432
Vipshop
VIPS
$7.22B
| $5.45M | 0.01% |
290,300
+46,230
| +19% | +$741K |
|
433
EPR Properties
EPR
$4.88B
| $5.43M | 0.01% |
97,216
+13,639
| +16% | +$739K |
|
434
BP
BP
$111B
| $5.39M | 0.01% |
124,976
-2,665
| -2% | -$110K |
|
|
ATHL
435
DELISTED
ATHLON ENERGY INC COM
ATHL
| $5.38M | 0.01% |
112,802
-200,510
| -64% | -$8.41M |
|
|
BFX
436
DELISTED
BowFlex Inc.
BFX
| $5.34M | 0.01% |
481,443
-320,541
| -40% | -$3.25M |
|
437
Sun Communities
SUI
$15.6B
| $5.32M | 0.01% |
106,730
+19,894
| +23% | +$938K |
|
438
Dr. Reddy's Laboratories
RDY
$9.8B
| $5.22M | 0.01% |
605,120
+59,820
| +11% | +$503K |
|
439
AbbVie
ABBV
$470B
| $5.21M | 0.01% |
92,372
+59,973
| +185% | +$3.15M |
|
440
Vanguard Total Bond Market
BND
$158B
| – | – |
0
| – | – |
|
|
GRT
441
DELISTED
GLIMCHER REALTY TRUST
GRT
| $5.17M | 0.01% |
477,526
+303,800
| +175% | +$3.19M |
|
|
WCN
442
Waste Connections
WCN
$43.6B
| $5.05M | 0.01% |
+155,997
| New | +$4.69M |
|
443
W.P. Carey
WPC
$16.6B
| $4.96M | 0.01% |
78,723
+14,717
| +23% | +$897K |
|
|
DX
444
Dynex Capital
DX
$3.19B
| $4.93M | 0.01% |
185,840
+37,767
| +26% | +$973K |
|
445
American Tower
AMT
$80.8B
| $4.93M | 0.01% |
54,819
+275
| +0.5% | +$23.8K |
|
446
F5
FFIV
$22.3B
| $4.92M | 0.01% |
44,165
-2,055
| -4% | -$221K |
|
447
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
| $4.88M | 0.01% |
109,500
+51,000
| +87% | +$2.26M |
|
448
Globalstar
GSAT
$10.2B
| $4.88M | 0.01% |
+76,558
| New | +$3.93M |
|
449
iShares Global Energy ETF
IXC
$2.75B
| $4.84M | 0.01% |
+99,815
| New | +$4.65M |
|
450
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.46B
| – | – |
0
| – | – |
|
Similar funds
QCM
Lazard Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Lazard Asset Management held 1,131 positions worth $47.8B, up 6.9% from $44.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Lazard Asset Management's Q2 2014 filing shows 130 new, 292 increased, 306 reduced and 143 closed positions. Its largest new stake was Ally Financial: 8,153,883 shares worth $195M. The largest sale was Gilead Sciences, an estimated $262M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Communication Services and Technology.
- Lazard Asset Management's largest Q2 2014 buy was Ally Financial: 8,153,883 shares worth $195M.
- Lazard Asset Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $526M increase.
- Lazard Asset Management's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $262M.
- Lazard Asset Management fully exited Mastercard in Q2 2014, selling an estimated $204M.
- Lazard Asset Management's ten largest holdings make up 18% of its $47.8B portfolio in Q2 2014.
- Lazard Asset Management opened 130 new positions and closed 143 in Q2 2014.
- Lazard Asset Management's portfolio value rose 6.9% quarter-over-quarter to $47.8B.
Based on Lazard Asset Management's 13F filing for Q2 2014, filed 12 Aug 2014.